84 related articles for article (PubMed ID: 9264325)
1. Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.
Parsons PG; Hansen C; Fairlie DP; West ML; Danoy PA; Sturm RA; Dunn IS; Pedley J; Ablett EM
Biochem Pharmacol; 1997 Jun; 53(11):1719-24. PubMed ID: 9264325
[TBL] [Abstract][Full Text] [Related]
2. Biphasic response of the metallothionein promoter to ultraviolet radiation in human melanoma cells.
Hansen C; Ablett E; Green A; Sturm RA; Dunn IS; Fairlie DP; West ML; Parsons PG
Photochem Photobiol; 1997 Mar; 65(3):550-5. PubMed ID: 9077140
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Wong SS; Sturm RA; Michel J; Zhang XM; Danoy PA; McGregor K; Jacobs JJ; Kaushal A; Dong Y; Dunn IS
Biochem Pharmacol; 1994 Mar; 47(5):827-37. PubMed ID: 7510966
[TBL] [Abstract][Full Text] [Related]
4. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
Fang D; Tsuji Y; Setaluri V
Nucleic Acids Res; 2002 Jul; 30(14):3096-106. PubMed ID: 12136092
[TBL] [Abstract][Full Text] [Related]
5. Effect of azelaic acid on melanoma cells in culture.
Lemic-Stojcevic L; Nias AH; Breathnach AS
Exp Dermatol; 1995 Apr; 4(2):79-81. PubMed ID: 7640879
[TBL] [Abstract][Full Text] [Related]
6. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture.
Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M
Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685
[TBL] [Abstract][Full Text] [Related]
7. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
[TBL] [Abstract][Full Text] [Related]
8. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
Fang D; Setaluri V
Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
[TBL] [Abstract][Full Text] [Related]
9. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture.
Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320
[TBL] [Abstract][Full Text] [Related]
10. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].
Geier G; Hauschild T; Bauer R; Kreysel HW
Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and a human melanoma cell line in tissue culture.
Robins EJ; Breathnach AS; Bennett D; Ward BJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Br J Dermatol; 1985 Dec; 113(6):687-97. PubMed ID: 4096883
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate.
Qiu L; Kelso MJ; Hansen C; West ML; Fairlie DP; Parsons PG
Br J Cancer; 1999 Jun; 80(8):1252-8. PubMed ID: 10376979
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
[TBL] [Abstract][Full Text] [Related]
14. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
Schallreuter KU; Wood JM
Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
[TBL] [Abstract][Full Text] [Related]
15. Effect of dicarboxylic (C6 and C9) acids on a human squamous carcinoma cell line in culture.
Pätzold HC; Breathnach AS; Robins EJ; Daridan ME; Bhasin YP; Ethridge LB; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1989 Apr; 4(2):167-71. PubMed ID: 2520453
[TBL] [Abstract][Full Text] [Related]
16. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
[No Abstract] [Full Text] [Related]
18. Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes.
Huang YH; Lee TH; Chan KJ; Hsu FL; Wu YC; Lee MH
J Dermatol Sci; 2008 Feb; 49(2):115-23. PubMed ID: 17766092
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
[TBL] [Abstract][Full Text] [Related]
20. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation.
Mastrofrancesco A; Ottaviani M; Aspite N; Cardinali G; Izzo E; Graupe K; Zouboulis CC; Camera E; Picardo M
Exp Dermatol; 2010 Sep; 19(9):813-20. PubMed ID: 20545756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
